Cho Soo Min, Lee Sejin, Yang Seung-Hoon, Kim Hye Yun, Lee Michael Jisoo, Kim Hyunjin Vincent, Kim Jiyoon, Baek Seungyeop, Yun Jin, Kim Dohee, Kim Yun Kyung, Cho Yakdol, Woo Jiwan, Kim Tae Song, Kim YoungSoo
Center for Neuro-Medicine, Hwarangno 14-gil 5, Seongbuk-gu, Seoul, Republic of Korea.
Biological Chemistry Program, Korea University of Science and Technology, 217 Gajungro, Yuseong-gu, Daejeon, Republic of Korea.
Sci Rep. 2016 Feb 2;6:20185. doi: 10.1038/srep20185.
Amyloid-β (Aβ) plays a critical role as a biomarker in Alzheimer's disease (AD) diagnosis. In addition to its diagnostic potential in the brain, recent studies have suggested that changes of Aβ level in the plasma can possibly indicate AD onset. In this study, we found that plasma Aβ(1-42) concentration increases with age, while the concentration of Aβ(1-42) in the cerebrospinal fluid (CSF) decreases in APPswe, PS1M146V and TauP301L transgenic (3xTg-AD) mice, if measurements were made before formation of ThS-positive plaques in the brain. Our data suggests that there is an inverse correlations between the plasma and CSF Aβ(1-42) levels until plaques form in transgenic mice's brains and that the plasma Aβ concentration possesses the diagnostic potential as a biomarker for diagnosis of early AD stages.
淀粉样β蛋白(Aβ)作为阿尔茨海默病(AD)诊断中的生物标志物发挥着关键作用。除了在大脑中的诊断潜力外,最近的研究表明,血浆中Aβ水平的变化可能预示着AD的发病。在本研究中,我们发现,在APPswe、PS1M146V和TauP301L转基因(3xTg-AD)小鼠中,如果在大脑中形成硫黄素S(ThS)阳性斑块之前进行测量,血浆Aβ(1-42)浓度会随着年龄增长而升高,而脑脊液(CSF)中Aβ(1-42)的浓度则会降低。我们的数据表明,在转基因小鼠大脑中形成斑块之前,血浆和脑脊液中Aβ(1-42)水平呈负相关,并且血浆Aβ浓度具有作为早期AD阶段诊断生物标志物的诊断潜力。